<DOC>
	<DOCNO>NCT00654407</DOCNO>
	<brief_summary>The purpose study determine whether treatment rosuvastatin follow atorvastatin simvastatin treatment improve health outcome patient high risk Coronary heart disease compare atorvastatin simvastatin alone .</brief_summary>
	<brief_title>Mercury II - Compare Efficacy Safety Lipid Lowering Agents Atorvastatin Simvastatin With Rosuvastatin High Risk Subjects With Type IIa IIb Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Hypolipidemic Agents</mesh_term>
	<criteria>Discontinuation cholesterol low drug , include dietary supplement . Documented history , high risk coronary heart disease establish atherosclerotic disease . The use lipid lower drug dietary supplement Visit 1 . Active arterial disease eg Unstable angina , recent arterial surgery Uncontrolled hypertension , hypothyroidism , alcohol drug abuse . Abnormal laboratory parameter define protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Cholesterol</keyword>
	<keyword>hypercholesterolemia</keyword>
	<keyword>Coronary Heart disease</keyword>
	<keyword>low density lipoprotein</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>simvastatin</keyword>
</DOC>